Marinus Pharmaceuticals Inc (MRNS)

May 14, 2025

Shareholders that Lost Money on Marinus Pharmaceuticals, Inc. (MRNS) Should Contact Levi & Korsinsky About Pending Class ActionMRNS - ACCESS Newswire

May 14, 2025

May 13, 2025

Marinus Pharmaceuticals (NASDAQ:MRNS) Now Covered by Analysts at StockNews.com - Defense World

May 13, 2025

May 12, 2025

Can The RAISE Study Data Give Marinus' Stock A Boost? - RTTNews

May 12, 2025

May 10, 2025

FINAL MRNS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

May 10, 2025

May 05, 2025

StockNews.com Begins Coverage on Marinus Pharmaceuticals (NASDAQ:MRNS) - Defense World

May 05, 2025

May 04, 2025

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Shares Sold by Geode Capital Management LLC - Defense World

May 04, 2025

May 04, 2025

JPMorgan Chase & Co. Purchases 354,393 Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - Defense World

May 04, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 26, 2025

Lost Money on Marinus Pharmaceuticals, Inc.(MRNS)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire

Apr 26, 2025

Apr 19, 2025

StockNews.com Initiates Coverage on Marinus Pharmaceuticals (NASDAQ:MRNS) - Defense World

Apr 19, 2025

Apr 14, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc.(MRNS) Shareholders - ACCESS Newswire

Apr 14, 2025

Apr 11, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc. (MRNS) Shareholders - ACCESS Newswire

Apr 11, 2025

Apr 06, 2025

Kiniksa Pharmaceuticals (NASDAQ:KNSA) versus Marinus Pharmaceuticals (NASDAQ:MRNS) Financial Analysis - Defense World

Apr 06, 2025

Apr 03, 2025

Fragile X Syndrome Market to Show Remarkable Growth Trends from - openPR.com

Apr 03, 2025

Apr 03, 2025

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Marinus - MarketScreener

Apr 03, 2025

Apr 01, 2025

Marinus pharmaceuticals director sells shares for $864 - MSN

Apr 01, 2025

Mar 29, 2025

MRNS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Mar 29, 2025

Mar 27, 2025

Status Epilepticus Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight | Marinus Pharma, Pfizer, UCB Biopharma SRL, Sage Therapeutics, Shire - The Globe and Mail

Mar 27, 2025

Mar 26, 2025

Dravet Syndrome Market Expected to Experience Major Growth - openPR.com

Mar 26, 2025

Mar 21, 2025

Refractory Status Epilepticus Treatment Market Size in 7MM - openPR.com

Mar 21, 2025

Mar 20, 2025

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Business Wire

Mar 20, 2025

Mar 20, 2025

Developmental and Epileptic Encephalopathies Treatment - openPR.com

Mar 20, 2025

Mar 02, 2025

Marinus Pharmaceuticals (NASDAQ:MRNS) Now Covered by StockNews.com - Armenian Reporter

Mar 02, 2025

Feb 27, 2025

MRNS LAWSUIT ALERT: Levi & Korsinsky Notifies Marinus Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Feb 27, 2025

Feb 26, 2025

Levi & Korsinsky Notifies Marinus Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMRNS - ACCESS Newswire

Feb 26, 2025

Feb 26, 2025

Long-Term Investors in Marinus Pharmaceuticals, Inc. (NASDAQ: - openPR

Feb 26, 2025

Feb 21, 2025

Class Action Filed Against Marinus Pharmaceuticals, Inc. (MRNS) Seeking Recovery for Investors – Contact Levi & Korsinsky - ACCESS Newswire

Feb 21, 2025

Feb 20, 2025

Marinus Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Feb 20, 2025

Feb 20, 2025

Class Action Filed Against Marinus Pharmaceuticals, Inc. (MRNS) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire

Feb 20, 2025

Feb 17, 2025

Marinus Pharmaceuticals director sells shares worth $869 - MSN

Feb 17, 2025

Feb 17, 2025

Marinus Pharmaceuticals CEO Scott Braunstein sells $167,530 in stock - MSN

Feb 17, 2025

Feb 17, 2025

Tuberous Sclerosis Complex Therapeutics Market Size Report - openPR

Feb 17, 2025

Feb 15, 2025

IMMINENT MRNS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire

Feb 15, 2025

Feb 14, 2025

Marinus Pharmaceuticals (NASDAQ:MRNS) Coverage Initiated at StockNews.com - Defense World

Feb 14, 2025

Feb 11, 2025

Marinus Pharmaceuticals (NASDAQ:MRNS) Acquisition Completed by Immedica Pharma AB - Defense World

Feb 11, 2025

Feb 11, 2025

Marinus Pharmaceuticals CEO Scott Braunstein sells $167,530 in stock By Investing.com - Investing.com UK

Feb 11, 2025

Feb 11, 2025

Immedica Pharma Completes Acquisition of Marinus Pharmaceuticals - TipRanks

Feb 11, 2025

Feb 10, 2025

Marinus Pharmaceuticals, Inc.Common Stock (NQ: MRNS - FinancialContent

Feb 10, 2025